RxDoctor Payments Data

Norman Chutkan, MD

Orthopaedic Surgery of the Spine · Phoenix, AZNPI 1689682890

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $72,970 of the $114,080 with a category attached, or 64.0%. Globus Medical accounts for 66.0% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2021 at $34,955 and has fallen 73.8% since, to $9,167 in 2025.

$114,080in general payments, 2019–2025

Across 186 payments — averaging $613.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Globus Medical$75K
  • Synthes GmbH$25K
  • Cerapedics Inc.$4K
  • Stryker$3K
  • Alphatec Spine, Inc$2K
  • Johnson & Johnson$2K
  • plus $3K from 20 others

What the payments were for

  • Royalty or licence$72,97064%
  • Consulting fees$5,7005%
  • Speaking & faculty fees$13,50012%
  • Travel & lodging$10,92810%
  • Food & beverage$10,5739%
  • Education$4090%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$114,080 in reported general payments places this provider in the 65th percentile of 64 orthopaedic surgery of the spine providers in Arizona.

See all orthopaedic surgery of the spine providers in Arizona

Medicare billing

Part B allowed, 2024
$157,088
Medicare patients
165
Services billed
656

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin35$329
Cyclobenzaprine Hcl22$290
Methylprednisolone26$181

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Phoenix

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →